From course:
(Practice similar questions for free)
DRUG DISCOVERY DEVELOPMENT (DDD)
» Start this Course(Practice similar questions for free)
Question:
FDA has an opportunity to review the IND application for safety to assure that research subjects will not be subjected to unreasonable risk
Author: LEIGHTON DWIGHT OBILLOSAnswer:
IND review
0 / 5 Â (0 ratings)
1 answer(s) in total
Author
LEIGHTON DWIGHT OBILLOS